Harnessing Evidence on Adverse drug withdrawal events following Deprescribing through the Pharmacovigilance system (HEAD-P)

Informations projet

HEAD-P

N° de convention de subvention: 101149577

DOI

10.3030/101149577

Projet clôturé

Date de signature de la CE 3 Mai 2024

Date de début 14 Octobre 2024

Date de fin 13 Octobre 2026

Financé au titre de

• Marie Skłodowska-Curie Actions (MSCA)

Coût total

Aucune donnée

Contribution de l’UE

€ 215 534,40

Coordonné par

ROYAL COLLEGE OF SURGEONS IN IRELAND
Ireland

CORDIS fournit des liens vers les livrables publics et les publications des projets HORIZON.

Les liens vers les livrables et les publications des projets du 7e PC, ainsi que les liens vers certains types de résultats spécifiques tels que les jeux de données et les logiciels, sont récupérés dynamiquement sur OpenAIRE .

Livrables

Data Management Plan (1)

Data Management Plan

The Data Management Plan describes the data management life cycle for all data sets that will be collected, processed or generated by the action. It is a document describing what data will be collected, processed or generated and following what methodology and standards, whether and how this data will be shared and/or made open, and how it will be curated and preserved.

Publications

Conference proceedings (3)

Abstracts of ISPEs 2026, 42nd International Conference, August 29–September 2, 2026, Milan

Publié dans: Pharmacoepidemiology and Drug Safety, Numéro 35, 2026, ISSN 1053-8569
Éditeur: Wiley
DOI: 10.1002/PDS.70409

24th ISoP Annual Meeting “Pharmacovigilance: Back to the Future” 24–27 October 2025 Cairo, Egypt

Publié dans: Drug Safety, Numéro 48, 2026, ISSN 0114-5916
Éditeur: Springer Science and Business Media LLC
DOI: 10.1007/S40264-025-01605-X

25th ISoP Global Meeting “Ecosystems of Trust: Pharmacovigilance for a Healthier World” 22–25 September 2026 San José, Costa Rica

Publié dans: Drug Safety, Numéro 49, 2026, ISSN 0114-5916
Éditeur: Springer Science and Business Media LLC
DOI: 10.1007/S40264-026-01704-3

Peer reviewed articles (3)

EPH108 Exploring the Impact of Patient Characteristics and Reporting Period on Adverse Drug Withdrawal Event Signals in the FAERS Database: A Stratified Disproportionality Analysis Study

Auteurs: Zakir Khan, Frank Moriarty
Publié dans: Value in Health, Numéro 28, 2025, ISSN 1098-3015
Éditeur: Elsevier BV
DOI: 10.1016/J.JVAL.2025.09.1237

Strengthening Pharmacovigilance Reporting for Withdrawal Reactions to Support Deprescribing

Auteurs: Zakir Khan, Frank Moriarty
Publié dans: Clinical Pharmacology & Therapeutics, Numéro 120, 2026, ISSN 0009-9236
Éditeur: Wiley
DOI: 10.1002/CPT.70356

Reporting patterns of adverse drug withdrawal events using individual case safety reports in the FAERS and Eudravigilance databases

Auteurs: Zakir Khan, Ann Sinéad Doherty, Caroline McCarthy, Kieran Dalton, Katharina Tabea Jungo, Emily Reeve, Frank Moriarty
Publié dans: Exploratory Research in Clinical and Social Pharmacy, Numéro 23, 2026, ISSN 2667-2766
Éditeur: Elsevier BV
DOI: 10.1016/J.RCSOP.2026.100828

Other (5)

Recommendations relating to adverse drug withdrawal events in clinical practice guidelines: a protocol for secondary analysis of a scoping review

Auteurs: Zakir Khan, Aili Langford, Amy Fallon, Ewurabena OfosuAikins, Shin J Liau, Emily Reeve, Frank Moriarty
Publié dans: OSF Registries, 2026
Éditeur: Center for Open Science

Evidence on drug withdrawal events after medication discontinuation: protocol for an overview of reviews

Auteurs: Zakir Khan, Katharina Tabea Jungo, Juliet Beatty, Pádraig Cullen, Anne Spinewine, Emily Reeve, Frank Moriarty
Publié dans: PROSPERO, 2025
Éditeur: Centre for Reviews and Dissemination, University of York / PROSPERO

Perspectives of stakeholders on the integration of adverse drug withdrawal events reporting in the pharmacovigilance system: a qualitative interview study protocol

Auteurs: Zakir Khan, Anais Essilini, Ann Sinéad Doherty, Michelle Flood, Barbara Clyne, Frank Moriarty
Publié dans: OSF Registries, 2026
Éditeur: Center for Open Science

Evidence on drug withdrawal events after medication discontinuation: protocol for an overview of reviews

Auteurs: Zakir Khan, Katharina Tabea Jungo, Juliet Beatty, Pádraig Cullen, Anne Spinewine, Emily Reeve, Frank Moriarty
Publié dans: OSF Registries, 2025
Éditeur: Center for Open Science

Reporting patterns and disproportionality analysis of adverse drug withdrawal events using individual case safety reports in US and European databases: a study protocol

Auteurs: Zakir Khan, Kieran Dalton, Katharina Tabea Jungo, Ann Sinéad Doherty, Emily Reeve, Frank Moriarty
Publié dans: OSF Registries, 2025
Éditeur: Center for Open Science